Latest Genentech Stories
In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative
Management Reportedly Tells Workers the Six Companies Will Drop Compass if they Vote for Union SAN FRANCISCO, Feb.
WHITE PLAINS N.Y., Feb.
SAN DIEGO and LAKE FOREST, Ill., Feb. 10, 2015 /PRNewswire/ -- Pfenex Inc.
CRESTWOOD, Ky., Feb. 10, 2015 /PRNewswire/ -- Apellis Pharmaceuticals, Inc.
RICHMOND, Va., Jan.
DALLAS, January 18, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014" to its store.
LA JOLLA, Calif., Jan. 14, 2015 /PRNewswire/ -- Human Longevity, Inc.
New program will support the identification of novel drug targets to treat Parkinson's disease MOUNTAIN VIEW, Calif., Jan.
CRESTWOOD, Ky., Nov. 20, 2014 /PRNewswire/ -- Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.